# Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformation

**Authors:** Hyejin Park, Jung-Eun Park, Bridger H. Freeman, Bosco Seong Kyu Yang, Shun-Ming Ting, Alexander K. Suh, Jude P.J. Savarraj, Shuning Huang, Jakob Körbelin, Huimahn Alex Choi, Sean P. Marrelli, Jaroslaw Aronowski, Peng Roc Chen, Eunhee Kim, Eun S. Park

PMC · DOI: 10.1172/jci.insight.195638 · JCI Insight · 2026-02-05

## TL;DR

This study shows that mutant KRAS in brain blood vessels activates microglia and macrophages, leading to dangerous bleeding in brain arteriovenous malformations.

## Contribution

The study reveals a novel mechanism linking endothelial KRAS mutations to immune cell activation and hemorrhage in bAVMs.

## Key findings

- KRASG12V in endothelial cells triggers microglia activation and macrophage infiltration in bAVMs.
- Activated microglia/macrophages correlate with blood-brain barrier leakage and hemorrhagic conversion.
- Depletion or inhibition of microglia/macrophages reduces intracerebral hemorrhage in bAVMs.

## Abstract

Mutation of KRAS in endothelial cells (KRAS-ECs) leads to intracerebral hemorrhage (ICH) in brain arteriovenous malformation (bAVM), resulting in severe disabilities or even death. However, it is unclear what causes this hemorrhagic conversion of bAVMs. Here, using a locally established, clinically relevant sporadic bAVM mouse model, created by overexpressing mutant KRAS (KRASG12V) in brain ECs, we demonstrate that KRAS-ECs act as trigger for activation of microglia (MG) and infiltration of macrophages (Mϕ). Using a 3-dimensional immunostaining approach with cleared human and mouse bAVM tissues, we demonstrate an abundance of MG/Mϕ around the bAVM nidus. The presence of MG/Mϕ was correlated to the blood-brain barrier leakage in bAVM areas. Time-lapsed intravital imaging in Cx3cr1-gfp;Ccr2-rfp reporter mice demonstrated the dynamic activation of MG and infiltration of Mϕ toward mutant KRASG12V–modified dysplastic vessels. Importantly, a time-course analysis showed that these activated MG and infiltrated Mϕ are present around the bAVMs prior to hemorrhagic conversion, and controlled depletion of MG/Mϕ reduced ICH incidence in bAVMs. Inhibition of MG/Mϕ with long-term minocycline treatment attenuated the incidence of ICHs around bAVMs. Our study indicates that MG/Mϕ are involved in destabilization of KRASG12V-induced bAVM, leading to hemorrhagic conversion/ICH. Thus, modulation of MG/Mϕ may reduce ICH risk in patients with bAVM.

The study focuses on the mechanism of intracerebral hemorrhage by understanding the role of microglia and macrophages in mutant KRAS-induced brain arteriovenous malformation.

## Linked entities

- **Genes:** KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845]
- **Chemicals:** minocycline (PubChem CID 54675783)
- **Diseases:** intracerebral hemorrhage (MONDO:0013792)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Kras (Kras proto-oncogene, GTPase) [NCBI Gene 16653] {aka K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2}
- **Diseases:** ICH (MESH:D002543), hemorrhagic (MESH:D006470), bAVM (MESH:D002538), arteriovenous malformation (MESH:D001165), death (MESH:D003643)
- **Chemicals:** minocycline (MESH:D008911)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** G12V

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13043085/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13043085/full.md

## References

81 references — full list in the complete paper: https://tomesphere.com/paper/PMC13043085/full.md

---
Source: https://tomesphere.com/paper/PMC13043085